Indian investigators have uncovered a counterfeit Keytruda network where hospital insiders refill used vials with non-therapeutic substances and sell them to cancer patients at below-market prices. At least one family received vials containing antifungal medication instead of the immunotherapy, priced at over ₹1.5 lakh

2mo ago · 1 min · Policy & Government

Revolution Medicines shares jumped sharply after clinical trial results for its cancer therapy were characterized as unprecedented. The data point carries outsized weight because RAS-targeted oncology is a historically resistant space where efficacy breakthroughs drive significant pipeline revaluation. Investor attenti

2mo ago · 1 min · Markets